Comparison of 208-week sequential therapy with telbivudine and entecavir in HBeAg-positive chronic hepatitis B patients with suboptimal responses to 24 weeks of Peg-IFNα-2a therapy: An open-labelled, randomized, controlled, “real-life” trialClinical Trial Published on 2017-11-012023-06-19 Journal: Journal of viral hepatitis [Category] B형 간염, [키워드] Chronic Hepatitis B peg-IFN Suboptimal responses telbivudine [DOI] 10.1111/jvh.12790 [Article Type] Clinical Trial
Hepatitis B surface antigen reduction by switching from long-term nucleoside/nucleotide analogue administration to pegylated interferonArticle Published on 2017-08-012023-06-19 Journal: Journal of viral hepatitis [Category] B형 간염, [키워드] Chronic Hepatitis B HBsAg peg-IFN sequential therapy [DOI] 10.1111/jvh.12691
What is new on HBsAg and other diagnostic markers in HBV infection?Review Published on 2017-06-012023-06-16 Journal: Best practice & research. Clinical gastroenterology [Category] B형 간염, [키워드] HBcrAg HBsAg HBV infection HBV RNA nucleos(t)ide analogues peg-IFN [DOI] 10.1016/j.bpg.2017.04.009 [Article Type] Review
Role of HBsAg decline in patients with chronic hepatitis B HBeAg-negative and E genotype treated with pegylated-interferonArticle Published on 2016-12-012023-06-19 Journal: Antiviral Research [Category] B형 간염, [키워드] HBeAg-negative HBV genotype hepatitis B treatment peg-IFN qHBsAg [DOI] 10.1016/j.antiviral.2016.10.011
Virological and serological tools to optimize the management of patients with chronic hepatitis BReview Published on 2016-01-012023-06-19 Journal: Liver international : official journal of the Inte [Category] B형 간염, [키워드] analogues Genotype HBV peg-IFN Personalized medicine prediction Prognosis [DOI] 10.1111/liv.12998 [Article Type] Review